Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ejim.2020.09.025 http://scihub22266oqcxt.onion/10.1016/j.ejim.2020.09.025 33032855!7534738!33032855     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\33032855.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Eur+J+Intern+Med 2020 ; 82 (ä): 7-15 Nephropedia Template TP {{tp|p=33032855|t=2020. Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery |pdf=|usr=}}{{33032855}} gab.com Text Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery JO: Eur J Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=33032855 #FOAvip Transthyretin amyloid cardiomyopathy (ATTR-AC) is an under-recognized and underdiagnosed disease. Although traditionally considered a rare condition, the epidemiology of the disease is rapidly changing due to the possibility of non-invasive diagnosis through cardiac scintigraphy with bone tracers and novel disease-modifying treatments providing survival advantages. Nevertheless, many questions and grey areas have to be addressed, such as the natural history of ATTR-AC, the role and implications of genotype-phenotype interactions, the best clinical management, prognostic stratification and the most appropriate treatments, including those already recommended for patients with heart failure. Clinicians have to cope with old beliefs and evolving concepts in ATTR-AC. A wide horizon of possibilities for physicians of many specialties is unfolding and awaits discovery. Twit Text FOAVip Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery ????Eur J Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=33032855 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33032855 #FOAvip English Wikipedia <ref>{{Cite pmid|33032855}}</ref> Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery #MMPMID33032855 Porcari A; Merlo M; Rapezzi C; Sinagra G Eur J Intern Med 2020[Dec]; 82 (ä): 7-15 PMID33032855show ga Transthyretin amyloid cardiomyopathy (ATTR-AC) is an under-recognized and underdiagnosed disease. Although traditionally considered a rare condition, the epidemiology of the disease is rapidly changing due to the possibility of non-invasive diagnosis through cardiac scintigraphy with bone tracers and novel disease-modifying treatments providing survival advantages. Nevertheless, many questions and grey areas have to be addressed, such as the natural history of ATTR-AC, the role and implications of genotype-phenotype interactions, the best clinical management, prognostic stratification and the most appropriate treatments, including those already recommended for patients with heart failure. Clinicians have to cope with old beliefs and evolving concepts in ATTR-AC. A wide horizon of possibilities for physicians of many specialties is unfolding and awaits discovery. |*Amyloidosis[MESH] |*Cardiomyopathies[MESH] |*Heart Failure[MESH] |Heart[MESH] |Humans[MESH]Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting (epmc).pdf DeepDyve Pubget Overpricing